[HTML][HTML] Rapid assays of SARS-CoV-2 virus and noble biosensors by nanomaterials

Y Liu, Y Li, Y Hang, L Wang, J Wang, N Bao, Y Kim… - Nano …, 2024 - Springer
The COVID-19 outbreak caused by SARS-CoV-2 in late 2019 has spread rapidly across the
world to form a global epidemic of respiratory infectious diseases. Increased investigations …

[HTML][HTML] COVID-19 and liver injury in individuals with obesity

IG Lempesis, E Karlafti, P Papalexis… - World Journal of …, 2023 - ncbi.nlm.nih.gov
Coronavirus disease 2019 is an infectious disease caused by the severe acute respiratory
syndrome coronavirus 2 that manifests as a variety of clinical manifestations, including liver …

[HTML][HTML] Liver injury induced by COVID 19 treatment–what do we know?

L Saha, S Vij, K Rawat - World Journal of Gastroenterology, 2022 - ncbi.nlm.nih.gov
The severity of coronavirus disease 2019 (COVID-19) may be correlated with the risk of liver
injury development. An increasing number of studies indicate that degrees of hepatotoxicity …

[HTML][HTML] Intestinal barrier dysfunction as a key driver of severe COVID-19

EP Tsounis, C Triantos, C Konstantakis… - World Journal of …, 2023 - ncbi.nlm.nih.gov
The intestinal lumen harbors a diverse consortium of microorganisms that participate in
reciprocal crosstalk with intestinal immune cells and with epithelial and endothelial cells …

[HTML][HTML] Outcomes of COVID-19 among patients with liver disease

I Vujčić - World Journal of Gastroenterology, 2023 - ncbi.nlm.nih.gov
Abstract Coronavirus disease 2019 (COVID-19) is primarily a respiratory disease with multi-
organ involvement, including impaired liver function. It has been noticed that a significant …

[HTML][HTML] COVID-19 and liver injury: An ongoing challenge

I Papagiouvanni, SC Kotoulas, A Pataka… - World Journal of …, 2023 - ncbi.nlm.nih.gov
The new coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was
identified in December 2019, in Wuhan, China. The virus was rapidly spread worldwide …

[HTML][HTML] Severity of COVID-19 in patients with diarrhoea: a systematic review and meta-analysis

S Dhakal, P Charoen, W Pan-Ngum, V Luvira… - Tropical Medicine and …, 2023 - mdpi.com
COVID-19 patients occasionally present with diarrhoea. Our objective was to estimate the
risk of developing the severe disease in COVID-19 patients with and without diarrhoea and …

[HTML][HTML] Prognostic Value of Transaminases and Bilirubin Levels at Admission to Hospital on Disease Progression and Mortality in Patients with COVID-19—An …

A Russo, M Pisaturo, R Palladino, P Maggi, FG Numis… - Pathogens, 2022 - mdpi.com
Introduction: Given the impact of COVID-19 on the world healthcare system, and the efforts
of the healthcare community to find prognostic factors for hospitalization, disease …

[HTML][HTML] A comparative analysis of liver injury markers in post-COVID syndrome among elderly patients: A prospective study

AV Bota, F Bratosin, SSS Bandi, I Bogdan… - Journal of Clinical …, 2024 - mdpi.com
Background: In the wake of the global COVID-19 pandemic, understanding its prolonged
impact on vulnerable populations has become a critical area of investigation. This study …

[HTML][HTML] The effects of hospitalisation on the serum metabolome in COVID-19 patients

T Hensen, D Fässler, L O'Mahony, WC Albrich, B Barda… - Metabolites, 2023 - mdpi.com
COVID-19, a systemic multi-organ disease resulting from infection with severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), is known to result in a wide array of …